Abstract
Patients with cardiac amyloidosis have a high incidence of symptomatic atrial fibrillation (AF) and frequently have difficulty tolerating rate-control therapy. Outcomes of catheter ablation for rhythm-control in patients with transthyretin (aTTR) cardiac amyloidosis have not been well described.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
